News & Events
Key Proteo Announces Acceptance of First Manuscript Publication to the International Journal for Neonatal Screening
The Copper Connection
Since the 1960s, the United States has been doing newborn screening (NBS) for various diseases…
Wilson Disease Association Invited Dr.Hahn to Speak about Newborn Screening for Wilson Disease at their Annual Conference
Key Proteo’s Petition Process to Washington State for Wilson Disease Adoption Updates
Key Proteo Presents Wilson Disease Pilot Study Updates
Key Proteo Exhibits at APHL 2024 Annual Conference
Mark Willig, President & Chief Executive Officer and Laureen Haynes, VP Business Development & Strategic Alliances
Key Proteo Announces Clinical Laboratory Expansion Plans Including New CLIA-Certified Laboratory
Key Proteo Raises $5 Million in Series A Financing to Advance Novel Immuno-SRM platform for Early Detection of Treatable Genetic Disorders
Key Proteo Announces New President and CEO
Key Proteo and Thermo-Fisher find Dynabead success together
Key Proteo and Thermo-Fisher find Dynabead success together
Congratulations Dr. Collins on your well-deserved success
2022 APHL NBS Symposium Award Ceremony
Key Proteo and Thermo-Fisher signed on MOU in August 2022
Key Proteo pilots newborn screening in Washington state
Key Proteo develops first newborn testing kit prototype
It all begins with an idea.